Related Experiment Videos
Ras farnesyltransferase: a new therapeutic target
1Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan 48105, USA.
Journal of Medicinal Chemistry
|September 25, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Real-time visualization of processive myosin 5a-mediated vesicle movement in living astrocytes.
The Journal of biological chemistry·2001
Characterization of the subunit structure of the catalytically active type I iodothyronine deiodinase.
The Journal of biological chemistry·2000
Cloning, expression, and functional characterization of the substrate binding subunit of rat type II iodothyronine 5'-deiodinase.
The Journal of biological chemistry·2000
Use of the Beck Depression Inventory for Primary Care to screen for major depression disorders.
General hospital psychiatry·1999
Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferase.
Journal of medicinal chemistry·1997
Discovery and Optimization of Novel Nonhydroxamate LpxC Inhibitors for the Treatment of Multidrug-Resistant Gram-Negative Infections.
Journal of medicinal chemistry·2026
Fragment-Based Discovery of Potent RNA-Competitive Inhibitors of the DEAH-Box RNA Helicase DHX8.
Journal of medicinal chemistry·2026
Discovery and Optimization of a WRN Helicase Inhibitor Series through Structure-Guided Drug Design from a Covalent Fragment Binding Insight.
Journal of medicinal chemistry·2026
Recent Advances in Antiviral Medicinal Chemistry against Flaviviruses Driven by Multistrategic Approaches.
Journal of medicinal chemistry·2026